(Q40599078)

21 September 2017

title

Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation (English)

1 reference

21 September 2017

2

Mattsson J

1 reference

21 September 2017

Remberger M

1

1 reference

21 September 2017

Ringdén O

series ordinal

3

1 reference

21 September 2017

publication date

1 August 2001

1 reference

Pediatric Transplantation

21 September 2017

published in

1 reference

21 September 2017

volume

5

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

285-292

1 reference

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

Bone marrow transplantation using unrelated donors for haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

Venoocclusive disease of the liver following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

Choosing an alternative bone marrow donor among available family members

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: Preliminary results

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Bl

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004285.X

7 January 2021

10.1034/J.1399-3046.2001.005004285.X

Identifiers

DOI

1 reference

21 September 2017

1 reference